2016
DOI: 10.1089/cren.2016.0106
|View full text |Cite
|
Sign up to set email alerts
|

Case Report of Percutaneous Tract Seeding of Renal Pelvic Tumor: 8-Year Journey

Abstract: A 58-year-old female presented with renal colic and was found to have renal transitional cell carcinoma at the time of percutaneous surgery. She developed percutaneous tract seeding that clinically presented as subcutaneous skin nodules. After local treatment with surgical excision and radiation treatment, the patient developed retroperitoneal recurrence 5 years later. Percutaneous tract seeding is rare. There is no general consensus on prevention of tract seeding during percutaneous resection of renal urothel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 4 publications
0
2
0
Order By: Relevance
“…To date, there are a total of 25 reported cases on tumor seeding along the percutaneous renal mass biopsy tract, from several case reports and one case series [8,[11][12][13][14][15][16]. Of these, PRCC (15 cases) was the most commonly encountered pathologic subtype.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…To date, there are a total of 25 reported cases on tumor seeding along the percutaneous renal mass biopsy tract, from several case reports and one case series [8,[11][12][13][14][15][16]. Of these, PRCC (15 cases) was the most commonly encountered pathologic subtype.…”
Section: Discussionmentioning
confidence: 99%
“…Historically, the rate of needle tract tumor seeding in renal biopsy was estimated to be as low as 0.01 % by Smith in 1991, and Herts and Baker in 1995 [9,10]. To date, only a handful of case reports and a small case series have been published [8,[11][12][13][14][15][16]. However, the frequency and clinical significance of biopsy-associated tumor seeding remains largely controversial due at least in part to lack of systemic review, histological analysis and follow up data in early studies [9,10,17].…”
Section: Introductionmentioning
confidence: 99%